Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma von Dickson, M.A., Mahoney, M.R., Tap, W.D., D'Angelo, S.P., Keohan, M.L., Van Tine, B.A., Agulnik, M., Horvath, L.E., Nair, J.S., Schwartz, G.K.

Volltext

Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors von Dickson, M.A., Okuno, S.H., Keohan, M.L., Maki, R.G., D'Adamo, D.R., Akhurst, T.J., Antonescu, C.R., Schwartz, G.K.

Volltext

Survival of Adult Rhabdomyosarcoma Patients Treated on Multimodality Protocols von Gerber, N, Leonard, W.H, Singer, S, Alektiar, K.M, Keohan, M.L, Wolden, S.L

Volltext

1752P A retrospective single-center study of outcomes to immune checkpoint blockade-based therapy in leiomyosarcoma von Babatunde, O., Rosenbaum, E., Kelly, C.M., Desir-Camille, R., Keohan, M.L., Banks, L., Avutu, V., Chan, J., Reed, D., Gounder, M., Maki, R.G., Chi, P., Dickson, M., Tap, W.D., D'Angelo, S.P., Movva, S.

Volltext

1775P Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas von Rosenbaum, E., Ehrich, F., Bradic, M., Kelly, C.M., Movva, S., Chan, J., Chi, P., Banks, L., Dickson, M., Keohan, M.L., Maki, R.G., Reiner, A., Adamow, M., Antonescu, C., Singer, S., Wong, P., Panageas, K., Tap, W.D., Shen, R., D'Angelo, S.P.

Volltext

1762P Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestin... von Kelly, C.M., Bradic, M., Saunds, S., Avutu, V., Chan, J., D'Angelo, S.P., Dickson, M., Gounder, M., Keohan, M.L., Movva, S., Rosenbaum, E., Bartlett, E.K., Crago, A., Strong, V., Singer, S., Antonescu, C., Berger, M., Qin, L-X., Tap, W.D., Chi, P.

Volltext

1720MO A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma von Rosenbaum, E., Qin, L-X., Dickson, M., Movva, S., Kelly, C.M., Chan, J., Chi, P., Banks, L., Keohan, M.L., Gounder, M., Maki, R.G., Cho, J., Biniakewitz, M., Desir-Camille, R., Erinjeri, J.P., Lefkowitz, R., Antonescu, C., Singer, S., Tap, W.D., D'Angelo, S.P.

Volltext

1527MO Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockade von Klemen, N.D., Hwang, S., Bradic, M., Rosenbaum, E., Dickson, M., Gounder, M., Kelly, C.M., Keohan, M.L., Movva, S., Thornton, K., Chi, P., Nacev, B., Chan, J.E., Bartlett, E.K., Richards, A.L., Singer, S., Donoghue, M., Tap, W., D'Angelo, S.P.

Volltext

Brain Metastases(BM) in Patients (PTS) with Soft Tissue and Bone Sarcoma (Sarcoma): A Retrospective Study of 107 Pts von Cioffi, A., Italiano, A., Maki, R.G., Keohan, M.L.

Volltext

1514 - Brain Metastases(BM) in Patients (PTS) with Soft Tissue and Bone Sarcoma (Sarcoma): A Retrospective Study of 107 Pts von Cioffi, A., Italiano, A., Maki, R.G., Keohan, M.L.

Volltext

Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma von Dickson, Mark A., Keohan, Mary Louise, Crago, A. M., Tap, William D., D’Angelo, S. P., Chi, P., Okoli, C., Schmidt, N., Lala, B., Sanchez, A., Kuk, D., Landa, J., Shoushtari, A. N., Gounder, Mrinal M.

Volltext

Angiosarcoma: Outcomes of systemic therapy for patients with metastatic disease von D’Angelo, S.P., Munhoz, R.R., Kuk, D., Landa, J., Hartley, E., Bonafede, M., Dickson, M.A., Gounder, M., Keohan, M.L., Crago, A.M., Antonescu, C.R., Tap, W.D.

Volltext

Gemcitabine for relapsed or resistant lymphoma von Savage, D. G., I Rule, S. A., Tighe, M., Garrett, T. J., Oster, W. M., Lee, R. T., Ruiz, J., Heitjan, D., Keohan, M. L., Flamm, M., Johnson, S. A.

Volltext

Supplementary Material for: Outcomes of Systemic Therapy for Patients with Metastatic Angiosarcoma von D'Angelo, S.P., Munhoz, R.R., Kuk, D., Landa, J., Hartley, E.W., Bonafede, M., Dickson, M.A., Gounder, M., Keohan, M.L., Crago, A.M.

Volltext bestellen